Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Multicenter Study Evaluating The Safety and Efficacy of BTDS in Subjects With Moderate to Severe Osteoarthritis Pain. Includes a 52-Week Extension Phase.

NCT00320801 is registered in ClinicalTrials.gov with Purdue Pharma LP as lead sponsor.

NCT NCT00320801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00320801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Multicenter Study Evaluating The Safety and Efficacy of BTDS in Subjects With Moderate to Severe Osteoarthritis Pain. Includes a 52-Week Extension Phase.
Lead sponsor
Purdue Pharma LP
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2004
Completion date
March 31, 2005
Enrollment
188 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis